Hannah Kalvin, MSPH

Research Biostatistician II
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Hannah Kalvin, MSPH

Research Biostatistician II
Share
Share
Hannah Kalvin

Email

[email protected]

Education

Emory University

Current Research Interest 

Hannah’s primary research collaborations at MSKCC include the Global Cancer Disparities Initiative (GCDI), Hepatopancreatobilliary (HPB) Surgery, and the Melanoma Service. She has also supported studies in Breast Surgery, Colorectal Surgery, and Lymphoma. Prior to working at MSKCC, Hannah worked at WCG Statistics Collaborative (formerly Statistics Collaborative, Inc.) from 2016-2019. She is interested in clinical trial analysis and design. Hannah is also a member of the Bridge to Biostats committee. 

Publications

  1. Pulvirenti, Alessandra MD, PhD*; Javed, Ammar A. MD†; Michelakos, Theodoros MD‡; Sekigami, Yurie MD‡; Zheng, Jian MD§; Kalvin, Hannah L. MSPH∥; McIntyre, Caitlin A. MD*; Nebbia, Martina MD‡; Chou, Joanne F. MS∥; Gonen, Mithat PhD∥; Raj, Nitya MD¶; Reidy-Lagunes, Diane L. MD¶; Zureikat, Amer H. MD§; Ferrone, Cristina R. MD‡; He, Jin MD, PhD†; Wei, Alice C. MD, MSc*;  Pancreatic Neuroendocrine Disease Alliance (PANDA). Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence, and Current Treatment. Annals of Surgery ():10.1097/SLA.0000000000005809, January 24, 2023. | DOI: 10.1097/SLA.0000000000005809
  2. Loo K, Kalvin HL, Panageas KS, Callahan MK, Chapman PB, Momtaz P, Shoushtari AN, Wolchok JD, Postow MA, Warner AB. Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1. Pigment Cell Melanoma Res. 2023 May-Jul;36(3-4):314-320. doi: 10.1111/pcmr.13083. Epub 2023 Apr 11. PMID: 37039320.
  3. Loo K, Kalvin HL, Panageas KS, Park V, Postow MA. Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment. Oncologist. 2022 Sep 2;27(9):e755-e758. doi: 10.1093/oncolo/oyac121. PMID: 35766876; PMCID: PMC9438908.
  4. Pak LM, Pawloski KR, Sevilimedu V, Kalvin HL, Le T, Tokita HK, Tadros A, Morrow M, Van Zee KJ, Kirstein LJ, Moo TA. How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy. Ann Surg Oncol. 2022 Oct;29(11):6706-6713. doi: 10.1245/s10434-022-11976-5. Epub 2022 Jun 14. PMID: 35699814; PMCID: PMC9196152.
  5. Elkrief A, Riccuiti B, Alessi JV, Fei T, Kalvin HL, Egger JV, Rizvi H, Thummalapalli R, Lamberti G, Plodkowski A, Hellmann MD, Kris MG, Arcila ME, Baine MK, Rudin CM, Lito P, Ladanyi M, Schoenfeld AJ, Riely GJ, Awad MM, Arbour KC. Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer. Oncologist. 2023 Aug 17:oyad197. doi: 10.1093/oncolo/oyad197. Epub ahead of print. PMID: 37589215.